Babe is the perfect blend of romance and attitude, with a romantic upswept eye and richly pigmented triple-layered acetate. This frame embodies the OGI ethos of creating bold yet wearable styles that are energetic, never eccentric.
Established in 1997, we’re a design house first, an innovator with a proven record of setting industry standards, of working with top tier manufacturers and suppliers to create new eyewear designs that stay ahead of the trends.
Our releases are frequent, distinct, and tell a consistent story without overlapping existing styles across Brands. Each one of our Brands tells a unique story that identify and serve a captive audience. Think durable, handcrafted frames designed to appeal to a diverse range of lifestyles so your clients can connect with the perfect piece instead of feeling shoehorned into a more generalized look.
Want to see more like this article? Click here to subscribe to our FREE print magazines and e- newsletters!
Kirk & Kirk Collaboration: Nicholas Pinnock (left) and Jason Bell (right)
Nicholas Pinnock and Jason Bell are long-time friends with a shared passion for eyewear.
When they realized that they were both friends with Jason Kirk through their love of glasses, they approached Kirk & Kirk to explore the idea of a collaboration. Jason and Karen Kirk loved the idea. Nicholas and Jason had a particular challenge that they wanted to address.
They often have to film in varied light conditions or go from outdoor to indoor events so they were looking for frames that would work both as sunglasses and as optical frames. Choosing a Transitions Amethyst lens, Kirk & Kirk adapted the ever-popular Horace in Matte Black to meet the challenge and wear in pretty much any environment.
Made in France to the highest optical standards, the lens can be adapted to carry a prescription with the Transitions lens. 10% of every sale goes to Little Green Pig, a children’s literacy charity based in Brighton, Kirk & Kirk’s home city.
Jason Bell
Jason is a former professional American footballer, who played as a cornerback/safety in the National Football League for the Dallas Cowboys. After completing his MBA Bell transitioned into media, co-hosting The Jason & Osi podcast with Osi Umenyiora and became co-presenter for the NFL show on the NFL show on ITV. He can also be seen regularly on Sky and hosts all the NFL UK Games and Super Bowl. He has starred in media campaigns for American Airlines, British Airways, Hyundai, Courtyard Marriott and most recently Wilson Sporting Goods.
Nicholas Pinnock
Nicholas Pinnock is a British actor and Producer. Pinnock has been seen across theatre, television and film for over 30 years. As well as playing the lead in For Life, productions include Marcella, Criminal,TheLastTree and Dark Encounter amongst many others. He can currently be seen in, The Book of Clarence (Sony) and will next be starring in LongBrightRiverfor Peacock. This year, he will also be seen in This Town, a limited series for BBC, Here, a film by Robert Zemeckis and Hedda (Amazon).
Marcolin and Skechers U.S.A., The Comfort Technology Company®, announce the renewal of their licensing agreement for the design, production and worldwide distribution of Skechers sunglasses, eyeglasses and kids’ eyewear.
The partnership, started in 2014, has been further extended until December 31, 2030.
The Skechers optical and sunglass collections offer an array of unique, expressive accessories for adults and children in Skechers’ iconic looks and colours. From classic profiles to trending shapes and athletic-inspired designs, Skechers Eyewear features key iconic elements including vivid prints and patterns, bright pops of colour and unique temple treatments. The Skechers Kids collection shines bright with sparkles and rhinestones, along with sporty, playful looks for active adventures.
Skechers Eyewear is available at authorized ecommerce retailers and opticians, and Skechers sunglasses are sold at select Skechers stores, department and independent retail stores worldwide and online at skechers.com.
The Wavefront Congress, a convergence of global experts and thought leaders in optical sciences and wavefront technologies for eye care, has recognized Arthur Bradley, Ph.D., Research Fellow at CooperVision, as a 2024 Luminary for his outstanding contributions to the optometry field for over more than four decades.
Celebrating Excellence in Optometry
Dr. Arthur Bradley
The honor was awarded to him during the annual event, which drew over 100 optical scientists, clinicians, surgeons, corporate scientists from around the world to Houston.
In addition to receiving his Luminary recognition, Dr. Bradley shared insights from his seven-year trial on the cumulative treatment effect and efficacy of MiSight® 1 day† contact lenses, presenting findings derived from the multi-year international clinical study. A prolific researcher, Dr. Bradley has authored nearly 200 scientific papers and over 200 abstracts to date.
Before joining CooperVision in 2019, Dr. Bradley built a celebrated career as a vision science professor and researcher at Indiana University. Throughout his tenure, he provided mentorship and guidance to the thousands of students he taught in various fields, including optics, visual neuroscience, binocular vision, and visual function.
“Dr. Bradley has made significant contributions to the field of optometry, especially in developing novel ways to examine the visual and ophthalmic systems. For decades he has been a Luminary to thousands of young scientists, as well as optometrists, ophthalmologists, and research peers, encouraging a deeper understanding of human vision and optics.”
Francis Erard, CooperVision’s Vice President of Research and Development
Groundbreaking Research and Mentorship
Dr. Bradley and the CooperVision Research and Development myopia team have garnered global recognition for groundbreaking research on optical interventions that are helping to address the myopia epidemic.* His significant contributions, particularly in the context of MiSight® 1 day, have propelled the fields of myopia control and myopia management forward.
Dr. Bradley’s work continues to receive widespread recognition and is regularly featured at major conferences. Last year, Dr. Bradley was inducted into the University of California Berkeley School of Optometry’s Hall of Fame
“Guiding the next generation of research scientists is an essential aspect of the scientific journey,” said Dr. Bradley. “Whether in a university or corporate setting, I believe we have an innate mentorship responsibility. Hopefully, this recognition will help shine a brighter spotlight on opportunities to collaborate with emerging ocular scientists, building an even more promising future together.”
Dr. Bradley was named a 2024 Luminary along with Dr. Ray Applegate, Dr. Larry Thibos, and Dr. Jim Schwiegerling (posthumously).
Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!
_____________________________
* MiSight® 1 day clinical study is the longest continuous soft contact lens study for myopia management.
† Canadian Indications for Use: MiSight 1 day (omafilcon A) Soft Contact Lenses for Myopia Control may reduce the rate of myopia progression in children (6-18) and correct ametropia. Reduction of myopia progression was observed in children with wearing time of 12 hours (8-16 hours) per day, 6.4 days (5-7) per week in a clinical study. Permanent myopia control after lens treatment is discontinued is not supported by clinical studies. MiSight (omafilcon A) Soft Contact Lenses for Myopia Control are indicated for single use daily disposable wear. When prescribed for daily disposable wear, the lens is to be discarded after each removal.
Alcon announces AcrySof® IQ Vivity® and Clareon® Vivity extended depth of focus (EDOF) intraocular lens (IOL) has surpassed more than one million implants worldwide. Vivity is the most implanted EDOF IOL globally.1* Alcon is the global leader in IOLs—every four seconds an eye is implanted with an Alcon IOL—and continues to innovate in this space to address patients’ unmet needs.5¤
“Reaching the one million milestone for Vivity, the world’s leading EDOF IOL, represents a meaningful achievement in restoring distance, intermediate and functional near vision for people worldwide, enabling them to get back to doing and seeing the things they love. Vivity offers patients who want less dependency on glasses a game-changing option with its monofocal visual disturbance profile, embodying our commitment to helping people live and see brilliantly.”
Mark Newson, Country Business Unit Head, Surgical Division at Alcon Canada
Vivity uses Alcon’s proprietary non-diffractive Wavefront-Shaping X-WAVETM technology, an advanced optical principal that simultaneously stretches and shifts light without splitting it— balancing quality of vision and maximizing range of vision.2,3 This unique mechanism of action is not refractive, does not introduce spherical aberrations and has ultimately expanded PCIOL access to even more patients.
Recent, large-scale real-world data underscores the impact of Vivity on patients across the globe. The Vivity Registry Study4+ demonstrates high patient satisfaction among several patient cohorts, as the vast majority of patients (92%) report they are satisfied with their sight∞ and three-quarters of patients report no difficulty with their sight for everyday activities.‡ With Vivity, more than 91% of patients report no halos, glares, or starbursts.† Additionally, nearly 50% of patients no longer need glasses for near activities; this percentage increases to 66% for patients who received monovision.
Vivity is available in more than 80 countries, including Canada and US. Alcon offers a family of leading IOLs designed to meet the unique vision needs of patients, including Vivity and PanOptix®—the most implanted PCIOLs worldwide—as well as Monofocal and Toric options. PanOptix surpassed 1M implants in early 2022, and is the most implanted trifocal worldwide.5,6
Alcon Data on File, US Patent 9968440 B2, May 15, 2018.
AcrySof® IQ Vivity® or Clareon® IQ Vivity® IOL Directions for Use.
Reus NJ, Kooijman M, Perez-Vives C. Overall Visual Outcomes from a Real-world Study of Presbyopia-correcting IOLs in a Large Population. Presented at the European Society of Cataract and Refractive Surgery (ESCRS) Annual Meeting; 8-12 Sept, 2023; Vienna, Austria.
Promotional Claim Supporting information PanOptix PC-IOL Family Product Code TFNT00.
Alcon IOL Global Sales; Jan 2021- Nov 2022.
* Based on worldwide sales of AcrySof IQ Vivity® and Clareon® Vivity ® IOLs
Presbyopia Correcting Intraocular Lens
+The Vivity® Registry Study was a multicentre, ambispective, non-comparative, open-label, non- interventional registry study conducted across 41 sites from eight (8) countries: Australia, Belgium, Germany, New Zealand, the Netherlands, Portugal, Spain and the United Kingdom.
‡CATQUEST 9SF, patients were asked: Do you have difficulty with the activities because of your sight? If so, to what extent?
∞Subject satisfaction was evaluated with the Catquest 9SF Questionnaire. Statistic refers to ‘very’ or ‘fairly’ satisfied.
†Visual disturbances were evaluated by asking open, non-prompted questions about visual experience.
§IOLSAT: In the past 7 days, how often did you need to wear eyeglasses to see?
The American Academy of Optometry (AAO) was recognized as a Cochrane Eyes and Vision (CEV) Center for Evidence-based Vision Care during Academy 2024 Indianapolis, November 6-9, 2024.
K-774’s retro-inspired look features patterned base acetate and custom lamination on the temple, creating a striking look where colours blend seamlessly.
Delve into the world of night vision technology. From thermal imaging to infrared systems, explore how these innovations improve our ability to see in the dark.
The American Academy of Optometry (AAO) was recognized as a Cochrane Eyes and Vision (CEV) Center for Evidence-based Vision Care during Academy 2024 Indianapolis, November 6-9, 2024.
K-774’s retro-inspired look features patterned base acetate and custom lamination on the temple, creating a striking look where colours blend seamlessly.
Delve into the world of night vision technology. From thermal imaging to infrared systems, explore how these innovations improve our ability to see in the dark.
The American Academy of Optometry (AAO) was recognized as a Cochrane Eyes and Vision (CEV) Center for Evidence-based Vision Care during Academy 2024 Indianapolis, November 6-9, 2024.
K-774’s retro-inspired look features patterned base acetate and custom lamination on the temple, creating a striking look where colours blend seamlessly.
Delve into the world of night vision technology. From thermal imaging to infrared systems, explore how these innovations improve our ability to see in the dark.
The American Academy of Optometry (AAO) was recognized as a Cochrane Eyes and Vision (CEV) Center for Evidence-based Vision Care during Academy 2024 Indianapolis, November 6-9, 2024.
K-774’s retro-inspired look features patterned base acetate and custom lamination on the temple, creating a striking look where colours blend seamlessly.
Delve into the world of night vision technology. From thermal imaging to infrared systems, explore how these innovations improve our ability to see in the dark.
